ELECTRONIC ARTICLE |



* Clinical Epidemiology Unit, Department of Pediatrics, and Departments of
Radiology
Emergency Medicine, and
|| Department of Bacteriology, Saint-Vincent-de-Paul Hospital, AP-HP, Université Paris V, Paris, France
¶ Institut National de la Santé et de la Recherche Médicale U149, Paris, France
| ABSTRACT |
|---|
|
|
|---|
Methods. A retrospective hospital-based cohort study included all children who were 1 month to 4 years of age and had a first febrile urinary tract infection. Univariate and multivariate analyses were performed.
Results. Among 136 patients included, 25% had vesicoureteral reflux. The median procalcitonin concentration was significantly higher in children with reflux than in those without (1.2 vs 0.6 ng/mL). High procalcitonin (
0.5 ng/mL) was associated with reflux (odds ratio [OR]: 4.6; 95% confidence interval [CI]: 1.616.2). After logistic-regression adjustment for all potential confounders, the association remained significant (OR: 4.9; 95% CI: 1.714.0). The relationship was stronger for high-grade (
3) reflux (OR: 8.7; 95% CI: 1.2382) than low-grade reflux (OR: 3.6; 95% CI: 1.115.3). High procalcitonin sensitivities were 85% (95% CI: 7094) and 92% (95% CI: 6599) for all-grade and high-grade reflux, respectively, with 44% specificity (95% CI: 3554).
Conclusion. High procalcitonin is a strong and independent predictor of vesicoureteral reflux and could be used to identify low-risk patients to avoid unnecessary voiding cystourethrography.
Key Words: children prediction procalcitonin urinary tract infection vesicoureteral reflux
Abbreviations: UTI, urinary tract infection VUR, vesicoureteral reflux PCT, procalcitonin OR, odds ratio CI, confidence interval
Urinary tract infection (UTI) is one of the most frequent bacterial infections in children.1 It has been estimated that 7% of girls and 2% of boys will have a UTI before 6 years of age.2 Vesicoureteral reflux (VUR) is diagnosed at the time of the first febrile UTI in 20% to 40% of children.3 VUR is a risk factor for relapsing UTI, renal scarring, hypertension, and renal failure.3 Thus, pediatric societies46 have recommended systematic voiding cystourethrography after the first febrile UTI in children. However, for 60% to 80% of the children, voiding cystourethrography is a posteriori normal. Moreover, this procedure has been associated with a risk for iatrogenic UTI7 and is irradiating, particularly for gonads,8 painful,9 and expensive.10 Therefore, it would be useful to be able to predict the absence of VUR so as to avoid unnecessary voiding cystourethrography.8
Two predictive tools have been proposed to define selective approaches for voiding cystourethrography. Renal ultrasonography alone, regardless of the criteria chosen, was shown to be poorly sensitive for VUR prediction.1114 A highly sensitive VUR risk score, combining clinical, biological, and radiologic variables, was also proposed,15 but we have shown that this score was poorly reproducible.16
Thus, new predictors of VUR after a first febrile UTI are needed to define selective approaches for voiding cystourethrography. Procalcitonin (PCT), a recently identified marker of inflammation,17 is a candidate because it was shown to be associated with renal scars,18,19 which are correlated with VUR.20 The aim of the present study was to analyze the relationship between PCT and VUR at the first febrile UTI in children.
| METHODS |
|---|
|
|
|---|
Patients
All patients with UTI as a discharge code or a text word in their computerized hospital records were considered for inclusion. All children who were 1 month to 4 years of age and admitted with a first episode of community-acquired febrile UTI were included. Febrile UTI was defined as a rectal temperature
38°C associated with a positive bacterial urine monoculture (
105 colony-forming units per mL in urine collected in sterile bags changed every 30 minutes or by midstream clean-void sample for older toilet-trained children) and a biological inflammatory syndrome (leukocyte count
15000/mm3 and/or C-reactive protein
15 mg/L). Patients with a known uropathy at the time of diagnosis were not included.
Outcome Definition
During the study period, all patients had undergone voiding cystourethrography, performed by a senior pediatric radiologist, who had been blinded to PCT results and potential confounders, and graded from 0 to 5, according to the International System of Radiologic Grading of Vesicoureteric Reflux.21 VUR then was classified as no VUR (grade 0), low-grade VUR (grades 1 and 2), and high-grade VUR (grade
3).12,13,20,22
PCT
At admission, the patient's serum PCT was measured prospectively using the LUMItest PCT immunoluminometric assay (BRAHMS, Hennigsdorf, Germany).
Potential Confounders
All risk factors for VUR previously described in the literature were a priori considered to be potential confounders: family history of uropathy,23,24 young age,3 male gender,3 and urinary tract dilation on renal ultrasonography,14 performed by a senior pediatric radiologist. The variables were dichotomized using previously proposed thresholds, as follows:
1 year 1, >1 year 0; boys 1, girls 0; first-degree family history of uropathy 1, no such history 0; and urinary tract dilation on renal ultrasonography 1, otherwise 0.
Statistical Analysis
Statistical analyses were performed using EPI INFO software (Centers for Disease Control and Prevention, Atlanta, GA) and Statview software (SAS Institute Inc, Cary, NC). First, we analyzed the distribution of PCT concentrations according to VUR grade. These distributions were compared using the Mann-Whitney nonparametric test. Second, PCT values were dichotomized using as the threshold the median of the distribution among patients without VUR, rounded off to the nearest half integer. Third, univariate analysis was conducted using the odds ratio (OR) and the
2 or Fisher's exact test to evaluate the relationship between high PCT (
0.5 ng/mL) and VUR for all patients and only girls. Fourth, the independence of this relationship was assessed after adjustment for all potential confounders using a logistic-regression model. Fifth, the relationship between high PCT and low-grade or high-grade VUR was examined using the
2 test for trend. Sixth, the discriminating power of a high PCT was determined by calculating its sensitivity and specificity for VUR.
| RESULTS |
|---|
|
|
|---|
The median age of the included children was 9.7 months (SD: 8.2); 63 (46%) patients were male. Thirty-two (24%) patients had a family history of uropathy; renal ultrasonography detected a urinary tract dilation in 26 (19%) patients. VUR was diagnosed in 34 (25%) children, including 12 (9%) with high-grade VUR.
The median PCT concentration was significantly higher in children with VUR than in those without (1.2 vs 0.6 ng/mL; P = .02; Fig 1). A PCT concentration of 0.5 ng/mL was selected as the threshold for dichotomization for the subsequent analyses (Table 1). Using this PCT threshold (
0.5 ng/mL), the OR between high PCT and VUR was 4.6 (95% confidence interval [CI]: 1.616.2; P = .002) for the entire population and 3.4 (95% CI: 1.013.1; P = .04) for female patients. Logistic-regression analysis was performed with the data of 131 (96%) patients, including 32 with VUR. Adjustment for all potential confounders yielded an OR of 4.9 (95% CI: 1.714.0; P = .003). The strength of the association increased significantly (P = .02) with the grade of VUR (Table 1), with the OR rising from 3.6 for low-grade VUR to 8.7 for high-grade VUR.
|
|
| DISCUSSION |
|---|
|
|
|---|
0.5 ng/mL) at admission. The association between high PCT and VUR was strong and remained so after adjustment for all potential confounders. Moreover, the relationship increased significantly and almost linearly with the VUR grade. A high PCT level predicted VUR with high sensitivity: >80% for all-grade VUR and >90% for high-grade VUR. In light of its specificity, this could avoid 44% of a posteriori normal voiding cystourethrographies. PCT, the prohormone of calcitonin, is an early, sensitive, and specific marker of bacterial infection.17,25 However, its role in the inflammatory response and in the cytokine cascade remains unknown.25 In febrile UTI, a high PCT concentration is a validated predictor of acute pyelonephritis26 (confirmed by early renal scintigraphy) and for late renal scars.18,19 The association between high PCT and VUR, especially high-grade VUR, could be explained by the risk for renal scarring that also increases with the VUR grade.20
In our retrospective study, 10 (6%) patients were lost to follow-up before voiding cystourethrography could be performed. This rate is close to that reported in other studies.14,20 Among the 13 (8%) patients for whom admission PCT values were not available, 3 had VUR (including 2 high-grade VUR). These missing data may have biased our results. However, even when we considered that those with VUR had low PCT concentrations and those without VUR had high PCT levels, the OR between a high PCT and VUR still would have been significant (2.4; 95% CI: 1.06.7; P = .04).
The use of sterile bags for urine collection introduced a selection bias, as this technique is less specific than suprapubic aspiration and not recommended by the American Academy of Pediatrics.4 Indeed, some patients who would not have had a diagnosis of UTI if suprapubic aspiration or catheterization had been used were included in our study. This bias explains the higher prevalence of boys in our study (46%) compared with other studies that use suprapubic aspiration or catheterization to diagnose UTI (11%, 28%).20,26 However, among female patients, the OR between a high PCT and VUR still was significant. Therefore, we considered that the selection bias could not explain our results. Moreover, sterile bags are used in routine practice by 25% of North American pediatricians27 and in many European countries.6,15
The PCT threshold of 0.5 ng/mL was used to dichotomize the variable. It was the same as that applied in previous studies on PCT as a predictor of renal scarring,18,26 and it is the lower limit of PCT in the semiquantitative doctor's bedside test.28
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
We thank Drs Ekindjan and Guérin for procalcitonin determinations. We also thank Maria Gonzales, Jennifer Renard, and Patricia Noble for technical support.
| FOOTNOTES |
|---|
Address correspondence to Martin Chalumeau, MD, PhD, Department of Pediatrics, Saint-Vincent-de-Paul Hospital, 74-82 Avenue Denfert Rochereau, 75014 Paris, France. E-mail: martin.chalumeau{at}wanadoo.fr
No conflict of interest declared.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S Leroy, E Marc, C Adamsbaum, D Gendrel, G Breart, and M Chalumeau Prediction of vesicoureteral reflux after a first febrile urinary tract infection in children: validation of a clinical decision rule Arch. Dis. Child., March 1, 2006; 91(3): 241 - 244. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||